The purpose of this study is to determine the effects of combined insulin and oral agent therapy in patients with insulin-requiring type II diabetes. The goal of this double-blind, placebo-controlled, cross-over study is to achieve euglycemia with combination therapy and insulin alone and to evaluate the effects of the two treatments on glucose, insulin levels and lipid metabolism.
Showing the most recent 10 out of 128 publications